These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3874341)

  • 1. Plasma levels of apoprotein B in patients with diabetes mellitus: the effect of glycemic control.
    Gonen B; White N; Schonfeld G; Skor D; Miller P; Santiago J
    Metabolism; 1985 Jul; 34(7):675-9. PubMed ID: 3874341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus.
    Attia N; Touzani A; Lahrichi M; Balafrej A; Kabbaj O; Girard-Globa A
    Diabet Med; 1997 Mar; 14(3):242-7. PubMed ID: 9088774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.
    Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C
    Metabolism; 1996 Apr; 45(4):430-4. PubMed ID: 8609827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoproteins and lipoproteins in children with type I diabetes: relation to glycosylated serum protein and HbA1.
    Strobl W; Widhalm K; Schober E; Frisch H; Pollak A; Westphal G
    Acta Paediatr Scand; 1985 Nov; 74(6):966-71. PubMed ID: 4090971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
    al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
    Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic control affects plasma lipid and apolipoprotein levels in women, but not in men, with IDDM.
    Benzi L; Marchetti P; Giampietro O; Miccoli R; Pecori N; Sanna G; Caricato F; Giovannitti MG; Ciccarone AM; Navalesi R
    Acta Diabetol Lat; 1988; 25(2):149-54. PubMed ID: 3223190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins.
    Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.
    Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid and lipoprotein aberrations in Indian patients with non-insulin-dependent diabetes in the young.
    Jialal I; Deppe W; Joubert SM
    S Afr Med J; 1985 Jun; 67(25):1001-4. PubMed ID: 4012462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.
    Petitti DB; Imperatore G; Palla SL; Daniels SR; Dolan LM; Kershnar AK; Marcovina S; Pettitt DJ; Pihoker C;
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):159-65. PubMed ID: 17283301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial changes in the distribution of apolipoprotein AIV between apolipoprotein B- and non apolipoprotein B-containing lipoproteins in obese women.
    Ferrer F; Nazih H; Zaïr Y; Krempf M; Bard JM
    Metabolism; 2003 Dec; 52(12):1537-41. PubMed ID: 14669151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?
    Alagözlü H; Gültekin F; Candan F
    Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):204-8. PubMed ID: 11079258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol metabolism and non-cholesterol sterol distribution in lipoproteins of type 1 diabetes: the effect of improved glycemic control.
    Sittiwet C; Gylling H; Hallikainen M; Pihlajamäki J; Moilanen L; Laaksonen DE; Niskanen L; Agren JJ; Laakso M; Miettinen TA
    Atherosclerosis; 2007 Oct; 194(2):465-72. PubMed ID: 16996519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fish oil concentrate on lipoprotein composition in NIDDM.
    Schectman G; Kaul S; Kissebah AH
    Diabetes; 1988 Nov; 37(11):1567-73. PubMed ID: 3181646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
    Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.
    Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A
    Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
    Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women.
    al-Muhtaseb N; al-Yusef AR; Bajaj JS
    Diabet Med; 1991 Oct; 8(8):732-7. PubMed ID: 1838064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus.
    Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG
    Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.